Unbalanced estrogen metabolism in thyroid cancer

Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk

(2012) Sandhya Pruthi et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Androstenediol complements estrogenic bioactivity during the menopausal transition

(2012) Bill L. Lasley et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Menopausal transition stage–specific changes in circulating adrenal androgens

(2012) Daniel S. McConnell et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

A High-Throughput Proteomic Approach Provides Distinct Signatures for Thyroid Cancer Behavior

(2011) S. Cheng et al.   CLINICAL CANCER RESEARCH

Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer

(2011) Ercole L. Cavalieri et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Thyroid Cancer Incidence and Survival in the National Cancer Institute Surveillance, Epidemiology, and End Results Race/Ethnicity Groups

(2010) Guo-Pei Yu et al.   THYROID

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

(2009) Nilesh W. Gaikwad et al.   BIOMARKERS

Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005

(2009) Amy Y. Chen et al.   CANCER

Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005

(2009) L. Enewold et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy

(2009) Guia Vannucchi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Novel biomarkers for risk of prostate cancer: Results from a case-control study

(2008) Li Yang et al.   PROSTATE